Last week, GenomeQuest announced whole-genome diagnostics reporting -- I thought that I'd offer some product and industry perspective on this news. The wonderful genetic experts at GeneTests have collected global research on over 2000 genetic disorders – GenomeQuest has built that database into its sequence analysis platform. From a single, whole-genome sequence ...
Earlier in the year I wrote an article about the growth curve of worldwide sequencing capacity based on current and expected placements of next-generation sequencing instruments. And while worldwide capacity increases at least at a doubling every year for the next five years, I am equally excited about the progress that has been ...
Join us at World Health Forum for announcement on collaboration with Harvard hospital re: pathology application of personalized (molecular) medicine: http://bit.ly/9te2En . Exciting to be a part of genomics arcing to ...
Illumina's HiSeq 2000 running at capacity can sequence two whole human genomes per week at 30x coverage - enough for a full-blown whole genome analysis. One instrument produces 104 human genomes per year. Beijing Genomics Institute alone has purchased 128 of these instruments. The Broad has 51. And based on Illumina's 2010 Q1 10-Q filing, they've ...
Good to see reasonably positive/researched/balanced reporting on genomics in a mainstream publication: http://www.economist.com/node/16349358?story_id=16349358. I believe that the public getting educated/excited about genomics-driven personalized medicine will accelerate the genomics "arc to clinical" -- a good thing, I think, for the life science community and the public at large. Some excerpts: ... the science of biology is ...
Last week, GenomeQuest held our "The Next Generation of Sequence Analysis" seminar for Harvard-based Researchers. It was sponsored by Bob Steen, manager of the Harvard Biopolymers Facility. According to Bob, it was the 2nd largest crowd ever for his seminars and the largest ever for a software topic -- an indicator that reseachers ...
The provocative title The Debt Crisis and the Human Genome belies Mike Mandels underlying message. I do worry that articles like this and the recent NY Times article A Decade Later, Human Genome Project Yields Few New Cures feed the cynics. Our society is so enamored with immediate gratification. Rome wasn't built in ...
This week, I attended the Consumer Genomics Show (more so a “clinical genomics" show). In a session on Next Generation Sequencing led by five industry experts, a recurring observation was that, on the one hand, steady investments in sequencing technology was indeed delivering breathtaking value and driving down sequencing costs – bravo indeed and ...
Lincoln Stein lays out "The case for cloud computing in genome informatics" pretty nicely. The article describes the inflection point of sequencing technology. That is from 1990 to 2004 'base-pair/$' doubled every 19 months versus a doubling every 5 months since 2004 to present. There is no end in sight. Moving data to the ...
Despite understandably varied opinions on the US federal government, I think that most of us can agree that U.S. National Institute of Health (NIH) has done remarkable things for the world and life sciences. They are the world driver and biggest supporter of genetic research, they largely funded the $3B Human Genome Project, and ...